VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ESMO Breast 2020 | Importance of biomarkers when evaluating heterogeneity in HER2+ metastatic BC

Maria Vittoria Dieci, MD, of the University of Padua, Padova, Italy, reviews how current biomarkers are used in the stratification of HER2+ metastatic breast cancer (BC). This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter